Cargando…
PRMT5-dependent p53 escape in tumorigenesis
Extensive studies have characterized mutational disruption of p53 signaling in human cancers. However, the mechanism for bypass of p53 function in tumors retaining wild-type p53 has remained ambiguous. Recent studies suggest that PRMT5, which is frequently elevated in human cancers, cooperates with...
Autores principales: | Li, Yan, Diehl, J. Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580063/ https://www.ncbi.nlm.nih.gov/pubmed/26425661 |
Ejemplares similares
-
PRMT5 prognostic value in cancer
por: Lattouf, Hanine, et al.
Publicado: (2019) -
The RP-Mdm2-p53 Pathway and Tumorigenesis
por: Miliani de Marval, Paula L., et al.
Publicado: (2011) -
PRMT5 is required for cell-cycle progression and p53 tumor suppressor function
por: Scoumanne, A., et al.
Publicado: (2009) -
PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis
por: Yin, Shasha, et al.
Publicado: (2021) -
Escape from IFN-γ-dependent immunosurveillance in tumorigenesis
por: Lin, Chiou-Feng, et al.
Publicado: (2017)